Key facts
- This page summarizes Philip L. Johnson's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2026, 18:04.
Philip L. Johnson - 30 Jun 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)
- Reporting relationship
- EVP & Chief Financial Officer
- Issuer ticker
- JAZZ
- Reported as of
- 30 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2026, 18:04:57 UTC
- Prior SEC filing
- 09 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- By: /s/Paz Dizon, as attorney in fact For: Philip L. Johnson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Philip L. Johnson filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 02 Jul 2026.
Change
- Previous filing in this sequence was filed on 09 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002013156
Primary reporting owner
Johnson Philip L
- Relationship
- EVP & Chief Financial Officer
- Address
- 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
- Signature
- By: /s/Paz Dizon, as attorney in fact For: Philip L. Johnson
- Signature date
- 02 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JAZZ
transaction
Ordinary Shares
Tax liability
- Transaction value
- Shares
- -3,343
- Change %
- -5.6%
- Price
- $237.72*
- Shares after
- 56,431
- Date
- 30 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
Footnote F2
The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026.